Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sun-Hee Kim

Showing results (541-550 of 556) with videos related to

Pageof 56
Sort By:
Leukemia|December 18, 2018
HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemiaJong-Ho Park, Young Min Woo, Emilia Moonkyung Youm, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2014
Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonistsDaniel J Buzard, Sun Hee Kim, Juerg Lehmann, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist seriesSangdon Han, Sanju Narayanan, Sun Hee Kim, et al.
Haematologica|December 18, 2009
UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosisHoi Soo Yoon, Hee-Jin Kim, Keon-Hee Yoo, et al.
Cancer Genetics and Cytogenetics|March 3, 2010
Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemiaSoo-Mee Bang, Ji-Weon Seo, Kyung Un Park, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Stephen E Webber, Martin T Tran, et al.
Leukemia & Lymphoma|April 10, 2008
Prognostic implications of the immunophenotype in biphenotypic acute leukemiaJe-Hwan Lee, Yoo Hong Min, Chul Won Chung, et al.
Journal of Clinical Laboratory Analysis|May 3, 2016
Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean PatientsEun-Hyung Yoo, Kyung-Jin Park, Hong-Hee Won, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.
Japanese Journal of Clinical Oncology|February 27, 2010
Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollmentHo-Jin Shin, Hyeoung-Joon Kim, Sang Kyun Sohn, et al.
Pageof 56

Showing results (541-550 of 556) with videos related to

Sort By:
Pageof 56
Leukemia|December 18, 2018
HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemiaJong-Ho Park, Young Min Woo, Emilia Moonkyung Youm, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2014
Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonistsDaniel J Buzard, Sun Hee Kim, Juerg Lehmann, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist seriesSangdon Han, Sanju Narayanan, Sun Hee Kim, et al.
Haematologica|December 18, 2009
UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosisHoi Soo Yoon, Hee-Jin Kim, Keon-Hee Yoo, et al.
Cancer Genetics and Cytogenetics|March 3, 2010
Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemiaSoo-Mee Bang, Ji-Weon Seo, Kyung Un Park, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Stephen E Webber, Martin T Tran, et al.
Leukemia & Lymphoma|April 10, 2008
Prognostic implications of the immunophenotype in biphenotypic acute leukemiaJe-Hwan Lee, Yoo Hong Min, Chul Won Chung, et al.
Journal of Clinical Laboratory Analysis|May 3, 2016
Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean PatientsEun-Hyung Yoo, Kyung-Jin Park, Hong-Hee Won, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.
Japanese Journal of Clinical Oncology|February 27, 2010
Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollmentHo-Jin Shin, Hyeoung-Joon Kim, Sang Kyun Sohn, et al.
Pageof 56